Jobs
-
Almirall has announced the filing of new applications for its Sativex endocannabinoid oromucosal spray for the treatment of spasticity in multiple sclerosis in ten additional countries: Belgium, Finland, Iceland, Ireland, Luxemburg, the Netherlands, Norway, Poland,… Read more . . .
-
Team Consulting has announced the opening of its new Respiratory Physics Laboratory at the company headquarters in Ickleton, Cambridgeshire, UK. Recent hire Mark Shepherd will manage the cGMP laboratory. “In recent years we have worked… Read more . . .
-
The FDA has accepted an Investigational New Drug application (IND) submitted by San Diego, CA pharmaceutical company Neurelis. The company is cleared to begin clinical trials for the development of its NRL-1 intranasal diazepam for… Read more . . .
-
According to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA), American pharmaceutical companies have 54 COPD medications in their pipelines. The list of drugs in development includes all dosage forms, including… Read more . . .
-
The new Medicon Valley Inhalation Consortium (MVIC) includes seven inhalation technology companies located in the Skåne-Copenhagen region of Scandinavia. According to the consortium, it “will work to globally promote Medicon Valley as an international center… Read more . . .
-
Bedford Laboratories has announced a national (US) voluntary product recall of acetylcysteine solution manufactured for Roxane Laboratories. The recall was initiated on December 20, 2011 due to a visible glass particle in a vial of… Read more . . .
-
Prosonix has announced the appointment of Geoff Down to the newly-created position of Chief Medical Officer, effective immediately. Down, who has extensive experience in clinical development and has served various roles, some as a consultant… Read more . . .
-
According to OptiNose, it filed an investigational new drug (IND) application for an intranasal sumatriptan product with the US FDA in December, 2011, and the FDA has given OptiNose permission to proceed. The company now… Read more . . .
-
Discovery Laboratories has announced that the FDA has approved the Afectair device for marketing in the US, and the company plans a launch later this year. The company describes Afectair as “a proprietary patient interface… Read more . . .
-
Following unprecedented growth in 2011 and to facilitate further growth and leadership succession, Team Consulting is looking to recruit a Commercial Director. You will be responsible for leading the continued profitable growth in sales. This… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA